These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4392244)

  • 41. Experimental central nervous system studies related to anaesthesia: clinical implications. 3. Effects of muscle relaxants on sensory inflow.
    Munroe JP; Jenkins LC; Ling GM
    Can Anaesth Soc J; 1966 Mar; 13(2):109-18. PubMed ID: 5959488
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of edrophonium, eserine, decamethonium, d-tubocurarine, and gallamine on the kinetics of membrane-bound and solubilized eel acetylcholinesterase.
    Robaire B; Kato G
    Mol Pharmacol; 1975 Nov; 11(6):722-34. PubMed ID: 1207670
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of so-called "depolarizing" and "repolarizing" substances on neuromuscular excitability].
    Quevauviller A; Levy JC
    Anesth Analg (Paris); 1967; 24(2):247-68. PubMed ID: 4383825
    [No Abstract]   [Full Text] [Related]  

  • 44. [Role of onium groups in the interaction of asymmetric bis-cationic cholinomimetics with N-cholinoreceptors].
    Gmiro VE; Khromov-Borisov NV; Danilov AF; Magazanik LG; Potap'eva NN
    Dokl Akad Nauk SSSR; 1977; 237(4):973-6. PubMed ID: 145360
    [No Abstract]   [Full Text] [Related]  

  • 45. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium].
    Danilov AF
    Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of depolarizing relaxants on the neuromuscular refractory period of anesthetized man.
    Epstein RA; Jackson SH
    Anesthesiology; 1973 Feb; 38(2):166-72. PubMed ID: 4684514
    [No Abstract]   [Full Text] [Related]  

  • 47. Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides.
    Bolger L; Brittain RT; Jack D; Jackson MR; Martin LE; Mills J; Poynter D; Tyers MB
    Nature; 1972 Aug; 238(5363):354-5. PubMed ID: 4627710
    [No Abstract]   [Full Text] [Related]  

  • 48. The interaction between magnesium and other neuromuscular blocking agents.
    Ghoneim MM; Long JP
    Anesthesiology; 1970 Jan; 32(1):23-7. PubMed ID: 5460601
    [No Abstract]   [Full Text] [Related]  

  • 49. Block by depolarization.
    Bowman WC
    Acta Anaesthesiol Scand; 1994 Aug; 38(6):529-32. PubMed ID: 7976139
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of histamine-N-methyltransferase activity by neuromuscular blocking drugs.
    Harle DG; Baldo BA; Fisher MM
    Agents Actions; 1985 Oct; 17(1):27-31. PubMed ID: 4083176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring of neuromuscular function.
    Ali HH; Savarese JJ
    Anesthesiology; 1976 Aug; 45(2):216-49. PubMed ID: 180849
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on the pharmacology of skeletal muscle in culture: specificity of receptors.
    Harvey AL; Dryden WF
    Eur J Pharmacol; 1974 Sep; 28(1):125-30. PubMed ID: 4154203
    [No Abstract]   [Full Text] [Related]  

  • 53. A novel monoquaternary neuromuscular blocking agent.
    Bamford DG; Biggs DF; Chaplen P; Davis M; Maconochie J
    Experientia; 1972 Sep; 28(9):1069-70. PubMed ID: 4198706
    [No Abstract]   [Full Text] [Related]  

  • 54. Neuromuscular blocking activity of a new series of quaternary N-substituted choline esters.
    Ginsburg S; Kitz RJ; Savarese JJ
    Br J Pharmacol; 1971 Sep; 43(1):107-26. PubMed ID: 4257628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ketamine: myoneural activity and interaction with neuromuscular blocking agents.
    Cronnelly R; Dretchen KL; Sokoll MD; Long JP
    Eur J Pharmacol; 1973 Apr; 22(1):17-22. PubMed ID: 4267587
    [No Abstract]   [Full Text] [Related]  

  • 56. The clinical use of muscle relaxants.
    Foldes FF
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):5-24. PubMed ID: 6049585
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of curariform compunds on the potentials of the cerebral cortex evoked by stimulation of the inferior cardiac and vagus nerves].
    Sinitsyn LN; Kharkevich DA
    Farmakol Toksikol; 1967; 30(4):423-7. PubMed ID: 5598893
    [No Abstract]   [Full Text] [Related]  

  • 58. Lack of neuromuscular blocking effect of chloramphenicol.
    Adams HR; Rossner SD
    Am J Vet Res; 1972 May; 33(5):1083-6. PubMed ID: 5023050
    [No Abstract]   [Full Text] [Related]  

  • 59. [Study of possible changes in curarization according to sex in adult Wistar rats].
    Bouyard P; Gastaut JA; Giudicelli H; Jadot G
    C R Seances Soc Biol Fil; 1972 Nov; 166(2):418-22. PubMed ID: 4267754
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of some guanidine derivatives on neuromuscular and ganglionic transmission.
    BARZAGHI F; MANTEGAZZA P; RIVA M
    Br J Pharmacol Chemother; 1962 Dec; 19(3):414-26. PubMed ID: 13969800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.